Avanos Medical, Inc.
Price Action
Technical Summary
STAGE 2 UPTRENDAvanos Medical, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 93), indicating clear outperformance against the broad market. Earnings contraction of 21% provides fundamental context to the price action. Investors should exercise caution due to high volatility (78% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $24.92 | -0.08% | BELOW |
| 50 SMA | $24.37 | +2.18% | ABOVE |
| 100 SMA | $19.16 | +29.98% | ABOVE |
| 150 SMA | $16.69 | +49.21% | ABOVE |
| 200 SMA | $15.43 | +61.39% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is AVNS in an uptrend right now?
AVNS has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, AVNS is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is AVNS overbought or oversold?
AVNS's RSI (14) is 71. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is AVNS outperforming the market?
AVNS has a Relative Strength (RS) Rating of 93 out of 99. Yes, AVNS is a market leader, outperforming 93% of all stocks over the past 12 months.
Where is AVNS in its 52-week range?
AVNS is trading at $24.90, which is 98% of its 52-week high ($25.49) and 96% above its 52-week low ($9.30).
How volatile is AVNS?
AVNS has a Beta of 1.37 and 52-week volatility of 78%. It's more volatile than the S&P 500 - expect bigger swings.